Skip to Content
  • Title
    CEO, GSK Consumer Healthcare
  • Company
    GSK
  • Country
    U.K.
  • Age
    47

Walmsley runs GSK’s $10 billion consumer healthcare unit, a portfolio of popular OTC brands including Horlicks, Sensodyne and Flonase that now accounts for 26% of the drugmaker’s 2015 sales. The division, formed in 2014 as a joint venture between Novartis and GSK, operates in 160 countries. In 2015, Walmsley continued to lead the integration of the business while getting good results: global sales for the group increased 44%; profits jumped 76%.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Personal Information

Country
U.K.
Previous Rank
#24 (EMEA)
Newcomer?
no

Company Financials

2015 Revenues
$36,550
2015 Profits
$12,867
Market Value (as of 8/26/16)
$105,168